Bilaketaren emaitzak - Linda Schäker‐Hübner

  • Erakusten 1 - 7 emaitzak -- 7
Findu emaitzak
  1. 1
    Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy

    Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy nork Fabian B. Kraft, Maria Hanl, Felix Feller, Linda Schäker‐Hübner, Finn K. Hansen

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase <b>6</b>

    Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase <b>6</b> nork Beate König, P. R. Watson, Nina Reßing, Abigail D. Cragin, Linda Schäker‐Hübner, D.W. Christianson, Finn K. Hansen

    Argitaratua 2023
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Development of the first non-hydroxamate selective HDAC6 degraders

    Development of the first non-hydroxamate selective HDAC6 degraders nork Tim Keuler, Beate König, Nico Bückreiß, Fabian B. Kraft, Philipp König, Linda Schäker‐Hübner, Christian Steinebach, Gerd Bendas, Michael Gütschow, Finn K. Hansen

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer

    HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer nork Robert Jenke, Denys Oliinyk, Tamara Zenz, Justus Körfer, Linda Schäker‐Hübner, Finn K. Hansen, Florian Lordick, Florian Meier-Rosar, Achim Aigner, Thomas Büch

    Argitaratua 2024
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors

    Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors nork Linda Schäker‐Hübner, Reza Haschemi, Thomas Büch, Fabian B. Kraft, Birke Brumme, Andrea Schöler, Robert Jenke, Jens Meiler, Achim Aigner, Gerd Bendas, Finn K. Hansen

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties

    Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties nork Viktoria Krieger, Alexandra Hamacher, Fangyuan Cao, Katharina Stenzel, Christoph G. W. Gertzen, Linda Schäker‐Hübner, Thomas Kurz, Holger Gohlke, Frank J. Dekker, Matthias U. Kassack, Finn K. Hansen

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia

    Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia nork Nina Reßing, Julian Schliehe‐Diecks, P. R. Watson, Melf Sönnichsen, Abigail D. Cragin, Andrea Schöler, Jing Yang, Linda Schäker‐Hübner, Arndt Borkhardt, D.W. Christianson, Sanil Bhatia, Finn K. Hansen

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: